Helex
Latest round
- Seed
Last raised
- Oct 2025
Total raised
- $3.5M
Investors
- 3
About Helex
a. Helex Bio, uses its proprietary genomics data, intelligent data-driven platform, and bioinformatics to design, validate and deliver therapy-specific gRNAs to businesses engaged in CRISPR-based genome editing therapeutics. In October 2025, Helex Inc. Bluehill Capital. Helex provides an intelligent GPS for gene-editing, which is the solution for drug discovery and CRISPR-based cell and gene therapies. In addition, the company’s services include custom-engineered guide RNAs, custom-engineered cell lines, and proprietary bioinformatics pipelines for detailed analysis of CRISPR edits.
Who invested in Helex
3 investors across 2 rounds
See all investors in Helex
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Helex
Who invested in Helex?
Helex has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Helex raised?
Helex has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Helex last raise money?
Helex's most recent round on record is a Seed, in Oct 2025.
What does Helex do?
Helex is a biotechnology company.
Where is Helex headquartered?
Helex is headquartered in New York, US.
Which VCs invest in companies like Helex?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Helex's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Helex? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.